Critical Care Solutions

from the 3M™ Cavilon™ Professional Skin Care Products Family

TM

Brand

Skin Protection
for the critically ill
Why is Skin Damage a Significant Problem?
• Skin damage constitutes a negative clinical outcome and a poor patient experience
•  ealing potential is significantly compromised(1) and skin damage has the potential to
H
create serious consequences, such as infection
• Skin damage increases the cost of care

So, prevention makes sense!

 Critical Care Patients are
at High Risk for Skin Damage
Incontinence
• 8.8–10.3% of ICU patients were found to have a pressure ulcer(2)
• Incontinence is a risk factor in the development of pressure ulcers
»  oisture on the skin increases friction and friction is a component of
M
Moisture shear, which can contribute to pressure ulcer formation
• Fecal incontinence and diarrhea are common in the critical care setting
» Patients with fecal incontinence are 22 times more likely to develop
a pressure ulcer(3)
Increased
Friction » 3 6–95% of ICU patients were found to have
Incontinence-Associated Dermatitis (IAD)(4,5)

Increased
Shear

Other significant sources of skin damage:

Increased Risk of
PU Formation • Adhesive damage associated with central venous
catheter care and negative pressure wound therapy
• Moisture associated skin damage from oral secretions, wound drainage,

perspiration, edema or leaking tubes/devices

• Friction damage from restlessness, immobility or obesity

Preventing
Skin Breakdown
Improves Clinical Outcomes
and Can Save Budget Dollars (9)
3M™ Cavilon™ No Sting Barrier Film:
Versatile to Meet Multiple Skin Protection Needs

Friction damage from

respiratory devices

Skin stripping from tape used

Skin stripping from adhesives: to secure endotracheal tubes
central line dressings

Damage to skin around mouth

(or tracheostomy) from saliva/secretions

Damage in skin folds from

moisture and friction
Damage around tubes or leaking drains

Friction over elbows

Moisture lesions over

sacrococcygeal area/buttocks

Skin stripping from adhesives: Incontinence-Associated Dermatitis

NPWT, tapes, dressings, ostomy pouches

Damage around fixators/pins

Damage from wound exudate or ostomy drainage Friction damage over heels

In one simple application, Cavilon™ No Sting Barrier Film can help you prevent damage
from friction, body fluids and adhesive trauma.

Skin Care Made Easy

P PREVENTION For Other
For Incontinence Skin Protection Needs
Use Cavilon™ No Sting Barrier Film when:
P TREATMENT
Use Cavilon No Sting Barrier Film:
™

• skin is damaged/broken
• skin is intact, but risk of damage is high
(e.g. frequent or continuous diarrhea)
• protection from friction is desired
• Reapply every 24 hours
•F or patients at higher risk of skin
damage (e.g. constant diarrheal
stooling) more frequent applications
(every 12 hours) may be necessary
• U nder adhesive dressings, tapes, or devices
—reapply each time the dressing and/or
adhesive product is changed
• F or peritube and periwound protection
—reapply every 24 hours or as needed
Create and Implement an Effective Skin Damage
Prevention Protocol with a Unique Skin Care Product!
3M™ Cavilon™ No Sting Barrier Film is an alcohol-free moisture barrier. Its unique formulation
contains a polymer that forms a waterproof, protective coating to protect the skin from body fluids,
adhesives and friction. It is breathable and transparent allowing for continuous visualization and
monitoring of skin, and conforms to the skin during movement or position changes.
• Fragrance-free, preservative-free • Cost effective(7, 8)
and latex-free (6)
• Compatible with chlorhexidine
• Hypoallergenic(6) gluconate (CHG)(6)
• Non-cytotoxic —can be used on
(6)

intact and damaged skin Evidence-based

There are over 70 pieces of clinical
Unique Formulation of not one but two polymers: evidence(9) supporting the efficacy and
cost-effectiveness of Cavilon™ No Sting
Terpolymer + Silicone Homopolymer = Effective Flexible Barrier Barrier Film for multiple clinical uses,
The additional polymer enables the film to flex with the skin and helps to maintain a continuous including prevention and treatment of
protective coating. Other barrier films contain only one polymer and some utilize alcohol as a solvent. IAD. This represents more evidence than
With Cavilon™ No Sting Barrier Film you can be confident that you have an effective barrier and any other moisture barrier or barrier film.
excellent patient comfort.

Ordering Information
3M™ Cavilon™ No Sting Barrier Film
Catalogue Items/ Boxes/
Product Size
No. Box Case
3346E 3M™ Cavilon™ No Sting Barrier Film 28 mL spray* 12 1

3345E 3M™ Cavilon™ No Sting Barrier Film 3.0 mL wand 25 4

Also available for other indications
3344E 3M™ Cavilon™ No Sting Barrier Film 1.0 mL wipe 30 6

3343E 3M™ Cavilon™ No Sting Barrier Film 1.0 mL peel-open wand 25 4 Spray Wand Wand Wipe
28 mL 3 mL 1 mL 1 mL
*The 28 ml spray is both convenient and economical to use for skin protection in the perineal/sacral area

References:
1.  Williams DT and Harding K. Healing responses of skin and muscle in critical illness.
Crit Care Med. 2003; 31(8): S547–557.
2.  VanGilder C. et al. Results of the 2008–2009 International Pressure Ulcer Prevalence Survey
and a 3-Year Acute Care, Unit Specific Analysis. Ostomy Wound Management. 2009;
55(11): 39–45.
3.  Maklebust J, Magnan M. Risk Factors Associated with Having a Pressure Ulcer:
A Secondary Data Analysis. Advances in Wound Care. 1994; 7(6): 25–42.
4.  Bliss DZ, Savik K, Thorson MAL, Ehman SJ, Lebak K, Beilman G. Incontinence associated
dermatitis in critically ill adults. J WOCN. 2011; 38(4): 433–45.
5.  Peterson KJ, Bliss DZ, Nelson C, Savik K. Practices of nurses and nursing assistants in
preventing incontinence associated dermatitis in acutely/critically ill patients.
Amer J of Crit Care. (Abstract.) 2006; 15(3): 325.
6.  3M Data on file.
7.  Bliss DZ, Zehrer CL, Savik K, Smith G, Hedblom E. An economic evaluation of four skin damage
prevention regimens in nursing home residents with incontinence. J WOCN. 2007; 34(2):
143–152.
8.  Bale S, Tebble N, Jones V, Price P. The benefits of implementing a new skin care protocol in
nursing homes. J of Tissue Viability. 2004; 14(2): 44–50.
9.  3M Health Care. Cavilon No Sting Barrier Film. Clinical Evidence Summaries. 2012.
TM

Available in Canada from:

Critical & Chronic Care Solutions Division
3M Canada Company 3M Health Care
P.O. Box 5757 2510 Conway Avenue
London, Ontario N6A 4T1 St. Paul, MN 55144 Please recycle. Printed in Canada.
Canada USA © 2014, 3M. All rights reserved.
1-800-563-2921 1-800-228-3957 3M and Cavilon are trademarks of 3M. Used under license in Canada.
www.3M.ca/skinwound www.3M.com/Cavilon 1401-00150E